Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Megan Ingram
Safety and Pharmacokinetics of Motesanib in Combination With Panitumumab and Gemcitabine-Cisplatin in Patients With Advanced Cancer
Journal of Oncology
Oncology
Related publications
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer
International Journal of Cancer
Cancer Research
Oncology
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Randomized Phase 2 Study of Gemcitabine and Cisplatin With or Without Vitamin Supplementation in Patients With Advanced Esophagogastric Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Safety, Pharmacological, and Biological Study of the Farnesyl Protein Transferase Inhibitor, Lonafarnib (SCH 663366), in Combination With Cisplatin and Gemcitabine in Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination With Chemotherapy in Asian Patients With Advanced Solid Tumors: Phase Ib Study
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers
Clinical Cancer Research
Cancer Research
Oncology
A Phase I/Ii Study of LY900003, an Antisense Inhibitor of Protein Kinase C- , in Combination With Cisplatin and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
